| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A response to the opioid overdose epidemic: naloxone nasal spray
|
Wermeling, Daniel P.
|
|
2012
|
3 |
1 |
p. 63-74
|
article
|
| 2 |
Clinical translation of RNAi-based treatments for respiratory diseases
|
Ballarín-González, Borja
|
|
2012
|
3 |
1 |
p. 84-99
|
article
|
| 3 |
Clinical translation of RNAi-based treatments for respiratory diseases
|
Ballarín-González, Borja
|
|
|
3 |
1 |
p. 84-99
|
article
|
| 4 |
CriticalSorb™: enabling systemic delivery of macromolecules via the nasal route
|
Lewis, Andrew L.
|
|
2012
|
3 |
1 |
p. 26-32
|
article
|
| 5 |
Current understanding of nasal morphology and physiology as a drug delivery target
|
Suman, Julie D.
|
|
2013
|
3 |
1 |
p. 4-15
|
article
|
| 6 |
High efficiency intranasal drug delivery using Intravail® alkylsaccharide absorption enhancers
|
Maggio, Edward T.
|
|
2012
|
3 |
1 |
p. 16-25
|
article
|
| 7 |
Microparticles based on chitosan/pectin polyelectrolyte complexes for nasal delivery of tacrine hydrochloride
|
Saladini, Bruno
|
|
2012
|
3 |
1 |
p. 33-41
|
article
|
| 8 |
Nasal delivery of fentanyl
|
Watts, Peter
|
|
2012
|
3 |
1 |
p. 75-83
|
article
|
| 9 |
Nasal drug delivery
|
Touitou, Elka
|
|
2012
|
3 |
1 |
p. 1-3
|
article
|
| 10 |
Nasal drug delivery devices: characteristics and performance in a clinical perspective—a review
|
Djupesland, Per Gisle
|
|
2012
|
3 |
1 |
p. 42-62
|
article
|
| 11 |
Strategies for intranasal delivery of vaccines
|
Zaman, Mehfuz
|
|
2012
|
3 |
1 |
p. 100-109
|
article
|
Journal description